logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
6/11/2018 8:34:26 AM Gilead Sciences’ Chief Scientific Officer John McHutchison Appointed Officer Of The Order Of Australia
6/4/2018 9:10:14 AM Kite Announces New Data Analyses For CAR T Therapy In Patients With Blood Cancers
5/31/2018 2:56:25 AM Gilead, Galapagos: EQUATOR Meet Primary Endpoint Of ACR20 Response At Week 16
5/30/2018 1:01:41 AM Gilead Sciences: China Drug Administration Approves Epclusa For Adults With Genotype 1-6 Chronic HCV Infection
5/15/2018 11:02:02 AM Gilead Sciences : FDA Oks Expanded Indication For Truvada For Reducing The Risk Of Acquiring HIV-1 In Adolescents
5/15/2018 8:34:13 AM Kite Reports Facilities & Expanded Collaboration With National Cancer Institute To Support Cell Therapy Pipeline
5/14/2018 4:01:18 PM Alpine Immune Sciences Q1 Loss/share $0.38 Vs. Loss $3.23 Year Ago
5/9/2018 4:31:23 PM Gilead Sciences Appoints Harish Manwani To Board Of Directors
5/1/2018 4:03:38 PM Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.57, Record Date 6/15/2018
5/1/2018 4:02:10 PM Gilead Sciences Q1 EPS $1.17 Vs $2.05 Last Year